Railway Pension Investments’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-15,000
| Closed | -$15.8M | – | 221 |
|
|
2024
Q3 | $15.8M | Sell |
15,000
-9,000
| -38% | -$9.46M | 0.19% | 129 |
|
|
2024
Q2 | $25.2M | Sell |
24,000
-4,100
| -15% | -$4.31M | 0.3% | 97 |
|
|
2024
Q1 | $27M | Buy |
28,100
+400
| +1% | +$385K | 0.26% | 115 |
|
|
2023
Q4 | $24.3M | Sell |
27,700
-54,000
| -66% | -$47.4M | 0.25% | 115 |
|
|
2023
Q3 | $67.2M | Sell |
81,700
-27,300
| -25% | -$22.5M | 0.73% | 48 |
|
|
2023
Q2 | $78.3M | Sell |
109,000
-28,700
| -21% | -$20.6M | 0.78% | 40 |
|
|
2023
Q1 | $113M | Buy |
137,700
+11,400
| +9% | +$9.37M | 1.16% | 31 |
|
|
2022
Q4 | $91.1M | Buy |
126,300
+52,300
| +71% | +$37.7M | 0.92% | 34 |
|
|
2022
Q3 | $51M | Hold |
74,000
| – | – | 0.55% | 54 |
|
|
2022
Q2 | $43.7M | Buy |
74,000
+29,100
| +65% | +$17.2M | 0.43% | 66 |
|
|
2022
Q1 | $31.4M | Sell |
44,900
-700
| -2% | -$489K | 0.24% | 101 |
|
|
2021
Q4 | $28.8M | Buy |
+45,600
| New | +$28.8M | 0.22% | 110 |
|
|
2021
Q1 | – | Sell |
-17,100
| Closed | -$8.26M | – | 248 |
|
|
2020
Q4 | $8.26M | Sell |
17,100
-26,500
| -61% | -$12.8M | 0.08% | 179 |
|
|
2020
Q3 | $24.4M | Buy |
43,600
+11,200
| +35% | +$6.27M | 0.25% | 100 |
|
|
2020
Q2 | $20.2M | Buy |
32,400
+17,800
| +122% | +$11.1M | 0.23% | 107 |
|
|
2020
Q1 | $7.13M | Buy |
+14,600
| New | +$7.13M | 0.1% | 188 |
|